Desq Long
Sign in

Company

Nurix Therapeutics, Inc.

NRIX · CIK 0001549595

SEC FORM 4
$50,462.64

Nurix Therapeutics, Inc. (NRIX)

Acquisition (code M) of 5,787 shares at $8.72 per share.

Reporting Person Ring Christine · Officer Title Chief Legal Officer · Transaction Code M

Traded Sep 2, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001817199-26-000030 · filed 2026-09-02 · View filing →

SEC FORM 4
$138,417.35

Nurix Therapeutics, Inc. (NRIX)

Sale of 5,387 shares at $25.6947 per share.

Reporting Person Ring Christine · Officer Title Chief Legal Officer · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001817199-26-000030 · filed 2026-09-02 · View filing →

SEC FORM 4
$10,655.00

Nurix Therapeutics, Inc. (NRIX)

Sale of 400 shares at $26.6375 per share.

Reporting Person Ring Christine · Officer Title Chief Legal Officer · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001817199-26-000030 · filed 2026-09-02 · View filing →

SEC FORM 4
$2,700.72

Nurix Therapeutics, Inc. (NRIX)

Acquisition (code M) of 1,452 shares at $1.86 per share.

Reporting Person Hansen Gwenn · Officer Title Chief Scientific Officer · Transaction Code M

Traded Sep 1, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0001817160-26-000019 · filed 2026-09-01 · View filing →

SEC FORM 4
$36,982.44

Nurix Therapeutics, Inc. (NRIX)

Sale of 1,452 shares at $25.47 per share.

Reporting Person Hansen Gwenn · Officer Title Chief Scientific Officer · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0001817160-26-000019 · filed 2026-09-01 · View filing →